Skip to main content
PLOS One logoLink to PLOS One
. 2022 Aug 5;17(8):e0272570. doi: 10.1371/journal.pone.0272570

Adherence to Covid-19 mitigation measures and its associated factors among health care workers at referral hospitals in Amhara regional state of Ethiopia

Agazhe Aemro 1, Beletech Fentie 2,*, Mulugeta Wassie 1
Editor: Paavani Atluri3
PMCID: PMC9355263  PMID: 35930572

Abstract

Introduction

With fragile health care systems, sub-Saharan Africa countries like Ethiopia are facing a complex epidemic, and become difficult to control the noble coronavirus. The use of COVID-19 preventive measures is strongly recommended. This study aimed to assess the adherence of COVID-19 mitigation measures and associated factors among health care workers.

Methods

A facility-based cross-sectional study was conducted among health care workers at referral hospitals in the Amhara regional state of Ethiopia from May 15 to June 10; 2021. It was a web-based study using an online questionnaire. STATA 14.2 was used for data analysis. Variables with a p-value<0.05 at 95% confidence level in multivariable analysis were declared as statistically significant using binary logistic regression.

Result

Adherence to COVID-19 mitigation measures was 50.24% in the current study. The odd of adherence of participants with a monthly income of ≥12801birr was 15% whereas the odds of adherence of participants who hesitate to take the COVID 19 vaccine were 10% as compared to those who don’t hesitate. Participants who had undergone COVID-19 tests adhered 6.64 times more than their counterparts. Those who believe adequate measurements are taken by the government adhered 4.6 times more than those who believe not adequate. Participants who believe as no risk of severe disease adhered 16% compared to those with fear of severe disease. Presence of households aged >60years adhered about 7.9 times more than with no households aged>60. Participants suspected of COVID-19 diagnosis adhered 5.7 times more than those not suspected.

Conclusion

In this study, a significant proportion of healthcare workers did not adhere to COVID-19 mitigation measures. Hence, giving special attention to healthcare workers with a monthly income of ≥12801 birr, being hesitant towards COVID-19 vaccine, being aged 26–30, and perceiving no risk of developing a severe infection is crucial to reduce non-adherence.

Introduction

The pandemic of COVID-19 entered Africa continent by the termination of February 2020 afterward it was professed a public health emergency of Worldwide Concern by the world health organization [1]. With fragile health care systems, African countries like Ethiopia are facing a complex COVID-19 epidemic, and it becomes a unbreakable duty to switch the virus reservoir, from where the virus may be introduce again to other regions [2].

Globally, COVID-19 affected more than 119.7 million people and 2.6 million deaths occurred [3] whereas in Africa over 4 million cases and 107 thousand deaths have been confirmed [4]. Considering the pandemic and lack of efficient management, government regulators’ in the globe designed different mitigation methods to battle the spread of the pandemic [5, 6]. To control the pandemic transmission, world health organization endorses reducing contact, early identification and isolation of cases, personal and material hygiene measures [6, 7].

As part of these measures, the use of face masks, hand washing, physical distancing, cough etiquette, and avoidance of crowded places are strongly recommended [7]. Even though adherence to preventive measures is the only means to tackle the disease, reluctance to do so has been reported to be a major problem everywhere [8].

Health care professionals are facing more workload, mental distress, scarcity of quality personal protective equipment, social exclusion, absence of motivations, coordination and good leadership throughout their service [9].

The good adherence to the COVID-19 pandemic mitigation measures was 51.04% and 8.3% in different Ethiopian studies conducted in the general community, but there is no information among health care providers [5, 8].

A substantial number of health care workers were reported to be infected with COVID-19 within the first six months of the COVID-19 pandemic, with the occurrence of hospitalization of 15.1% and mortality of 1.5% [10].

Health care providers are also facing many challenges like physical and mental affects, stigma and discrimination, fear of infection, and overall trying their best to keep it together. Health care providers could forget the mitigation measures of COVID-19 due to high workload, stress and related factors which will cause significant disruption of prevention chains of the disease [11, 12].

As far our search, there is no research conducted among health care workers in the current study setting and it is also true in the country as large. Therefore, this study intended to assess the adherence of COVID-19 mitigation measures and their associated factors among health care providers in the Amhara region regional state of Ethiopia.

Methods and materials

Study design, period and setting

A facility-based cross-sectional study was conducted from May 15 to June 10; 2021. It was a Web-based anonymous study using an online questionnaire. The study was conducted at referral hospitals in the Amhara regional state. According to the Amhara national regional health bureau annual performance report, the region has 81 hospitals, 858 health centers, and 3560 health posts. Among the hospitals in the region, the University of Gondar, Dessie, Felege-Hiwot, Tibebe-Ghion, Debre-Markos, Waldiya, Debre Tabor, and Debre Berhan are referral hospitals (Fig 1). The health care professionals working in these hospitals are estimated to be 4,000 [13, 14].

Fig 1. Schematic presentation of referral hospitals in Amhara regional state, Ethiopia.

Fig 1

Study participants

Telegram and email (the most popular social media platforms in Ethiopia) were used to promote and circulate the survey link to the participants. Data collectors in each hospital were asked to distribute the survey link to the randomly selected contacts in each hospital. The participants were informed that their participation was based on voluntariness, and consent was implied through their completion of the questionnaire. The respondents working during the data collection period were included in the current study.

Sample size determination

The sample size was determined using the single population proportion formula taking the proportion of compliance to the COVID19 preventive measures 22% [15], 95% confidence interval, and 4% marginal error. After adding a 5% non-response rate, the final sample size was ⁓433.

Sampling procedure

There are about 4,000 health care workers in Amhara regional state referral hospitals(906 in Gondar hospital, 320 in Debre tabor hospital,255 in Tibebe Ghione hospital,917 in Felege Hiot hospital,430 in Debre Markos Hospital,604 in Dessie hospital,300 in Waldiya hospital and 270 in Debre Berhan hospital). The entire sample size was first allocated proportionally to those eight referral hospitals. In order to select study participants from each hospital, first, the list of active healthcare workers during the study period was taken from the human resource management office of each hospital. Since the data was collected using telegram or e-mail, healthcare workers with no recorded information at either of these two addresses were excluded from the study. After that, a random number was generated on the computer, and by using this number and based on the allocated sample size, study participants were selected. Finally, the link of the questionnaire was given to the data collectors and forwarded to randomly select health care workers of respected hospitals, using e-mail or telegram. The link was forwarded to each hospital’s data collector to avoid coverage bias and to be representative.

Operational definitions

Good adherence of COVID-19 mitigation measures

Adherence in the current study was measured as participants who adhered (responded “yes”) to all of the three basic preventive measures (Wearing a mask, keeping physical distancing of a minimum of 2 meters, and Handwashing a minimum of ≥6 times/ day) and measured ‘Yes’ or ‘No’ answers to the questions. The specific questions used to assess the adherence of mask wearing, hand washing and physical distancing were asked as “have you wear face mask every time you leave home and never remove it from the face? (Yes/ No), do you wash your hand with soap at least six times per day during the Covid-19 pandemic? (yes/no) and are you fully compliance with physical distancing (≥2 meter) during the Covid-19 pandemic?(Yes/no) respectively. Individual participants who respond “Yes” for each component were adhered for mitigation measures in the current study. Participants who did not adhere even one of the three components of the mitigation measures were considered not adhered at the whole. We have summed all the three components and calculated the whole adherence.

Health care worker (HCW)

Any member of the health care unit that includes medical doctors, pharmacists, physiotherapists, midwifery, laboratory technologists, nursing professionals, or any other person in the course of his or her professional activities who may prescribe, administer, or dispense a medicinal product to an end-user [16].

Vaccine hesitancy

World Health Organization (WHO) declared vaccine hesitancy as "the reluctance or refusal to vaccinate despite the availability of vaccines" [17]. Respondents said to be hesitant to the vaccine if they respond “No” to the question “By the time you get a chance for Covid-19 vaccine, will you take the vaccine without any refusal?”.

Perceived susceptibility COVID-19 infection

Refers to a participant’s subjective perception of the risk of acquiring COVID-19 and is measured as High, Moderate, Low, No risk, or not sure [18].

Perceived severity of COVID-19 infection

Refers to a person’s subjective perception of the seriousness of contracting COVID-19 and measured as High, Moderate, Low, No risk, or not sure [18].

Data processing and analysis

The responses from the participants were downloaded in Excel using Google Forms. The data were checked for completeness and consistency, then compiled and coded. Then, it was exported to STATA version 14.2 statistical software for analysis. A binary logistic regression was employed to identify factors associated with adherence to COVID-19 mitigation measures. Initially, bivariate analysis was done, and variables with a p-value of 0.2 or below were identified as candidates for multivariable analysis. Then, multivariable analysis was done, and the adjusted odd ratio with a 95% confidence interval was computed and interpreted. A p-value of less than 0.05 is the cut-off point for determining the significance of an association. Finally, the result of the study was presented in text and tables.

Data quality assurance

The web-based self-administered questionnaire was pretested by taking 5% of the sample size before the actual data collection period. Afterward, the pretests, amendments to the tool, like formatting were corrected. The tool was first developed in the English language and was translated into the local language (Amharic) with back translation to English to check its consistency. Moreover, Cronbach’s alpha value was calculated to check the tools’ reliability and the value of an item score was 0.892.

Ethics approval and consent to participate

This study was approved by the institutional review board (IRB) of the University of Gondar. Written informed consent was obtained from each participant using communication channels (telegram and email) and those who agreed to participate were included in the study. Respondents were informed that their participation was voluntary and their confidentiality was maintained by avoiding registration of personal identifiers like names on the questionnaire and also, no raw data was given to anyone other than the investigator. In addition, the raw data is secured by a strong computer password.

Results

Socio-demographic characteristics of study participants

From the total 433 samples, 418 participants completed the questionnaire that yielded a 96.5% response rate. The mean age of study participants was 29.95 in the current study. More than half of the participants were under the age category of 26–30 years and nearly two-thirds were males. About 54% were married, 55% BSc and below educational level. The majority of the study participants have a monthly income in the category of 6991–12800 birr. Based on family size, 53.35% have less than or equal to 2 and nearly one thirds (31.58%) have children with school-age (Table 1).

Table 1. Socio-demographic characteristics of study participants (N = 418).

Variables Category Frequency Percent (%)
Age ≤25 49 11.72
26–30 234 55.98
≥31 135 32.30
Sex Female 129 30.86
Male 289 69.14
Marital status Single 194 46.41
Married 224 53.59
Educational status BSc and below 230 55.02
MSc and above 188 44.98
Monthly income <6990 27 6.46
6991–12800 357 85.41
≥12801 34 8.13
Family size ≤2 223 53.35
3–4 128 30.62
≥5 67 16.03
School-age children No 286 68.42
Yes 132 31.58

COVID-19 related characteristics of study participants

Nearly two-thirds (63.64%) of the participants were socially isolated because of their profession. About 59% underwent the COVID test and 44% were confident in health care services delivered on their institution whereas 45.69% got unclear information by health authorities related to the COVID-19 pandemic. Only100 (23.92%) believe measurements taken by the national government related to COVID-19 preventive measures are adequate. More than half (52.39%) of participants reported that they are at higher risk of COVID-19 infection but 53.35% believe they are at low risk to develop the severe disease if infected with the coronavirus. Nearly two-thirds (63.64%) had good compliance on social isolation if suspected to COVID-19 whereas 57.89% were suspected of COVID-19 diagnosis. About 55% perceive that their health status was very good. Only 3.83% have autoimmune diseases taking steroidal drugs. Nearly 54% of the participants were willing to take the COVID-19 vaccine but about 19% are confident in the current vaccine (Table 2).

Table 2. COVID-19 related characteristics of the study participants (N = 418).

Social isolation No 152 36.36
Yes 266 63.64
Undergone COVID test No 172 41.15
Yes 246 58.85
Confident in health care services Not confident 194 46.41
Confident 184 44.02
Very confident 40 9.57
Information by health authorities Clear 134 32.06
Inconsistent 93 22.25
Unclear 191 45.69
Measurements by Gov’t Not very adequate 186 44.50
Not adequate 132 31.58
Adequate 100 23.92
Risk to get COVID-19 infection Low 96 22.97
Moderate 103 24.64
High 219 52.39
Risk to sever COVID-19 disease Moderate/high 115 27.51
Low 223 53.35
No/not sure 80 19.14
Households age >60 years No 355 84.93
Yes 63 15.07
Compliance to social isolation No 152 36.36
Yes 266 63.64
Suspected COVID-19 Diagnosis No 176 42.11
Yes 242 57.89
Undergone COVID-19 test No 172 41.15
Yes 246 58.85
Perception of your health status Good 183 43.78
Very bad 7 1.67
Very good 228 54.55
Autoimmune problem /taking steroid No 402 96.17
Yes 16 3.83
Will you take COVID-19 vaccine No 192 45.93
Yes 226 54.07
Confident in the current COVID-19 vaccine Confident 80 19.14
Not confident 100 23.92
Not very confident 230 55.02
Very confident 8 1.91

Adherence towards COVID-19 mitigation measures

The Adherence towards COVID-19 mitigation measures among health care workers in the current study was 50.24[95%CI (45.44–55.04)]. Adherence to COVID-19 measures was 71.29%, 73.21%, and 56.94% for wearing a mask, washing hands ≥6 times per day based on WHO hand washing rules, and physical distancing of at least 2 meters respectively (Fig 2).

Fig 2. Distribution of adherence of COVID-19 mitigation measures among health care workers in referral hospitals of Amhara regional state of Ethiopia.

Fig 2

Factors associated with adherence of COVID-19 mitigation measures

Binary logistic regression was employed to identify independent factors that can affect the outcome variable. In bivariable analysis, monthly income, hesitancy to take COVID-19 vaccine, age, marital status, undergone COVID-19 test, the information given by health authority, measures taken by the national government, the risk to get COVID-19 disease, risk of severe COVID-19 disease, household age >60 years, suspected to COVID-19 infection, Comorbidity and confident on the current COVID-19 vaccine were associated with the outcome variable.

But in multivariable analysis, monthly income, hesitancy to take COVID-19 vaccine, age, undergone COVID-19 test, measures taken by the national government, household aged >60 years, and suspected to COVID-19 infection were statistically significant variables that affected adherence of COVID-19 mitigation measures.

Study participants with a monthly income of ≥12801birr adhered to COVID-19 measures 15% taking monthly income of ≤6990 as reference [AOR = 0.15, 95%CI (0.02–0.92)]. Participants who hesitate to take COVID 19 vaccine adhered 10% [AOR = 0.10, 95%CI (0.04–0.25)] as compared to those who don’t hesitate. Those participants with the age group of 26–30 years adhered to mitigation measures 9% [AOR = 0.09, 95%CI (0.02–0.39)] compared to age groups <26 years. Study participants who underwent the COVID-19 test adhered to about 6.6[AOR = 6.64, 95%CI (3.10–14.22)] times more than those who didn’t undergo the test. Participants who believe adequate measurements are taken by the government adhered to about 4.6 [AOR = 4.60, 95%CI (1.66–12.78)] times more than those who believe measurements are not adequate. Participants who believe with no risk of severe COVID-19 disease adhered 16% [AOR = 0.16, 95%CI (0.06-.46)] as compared to those with fear of severe COVID-19 disease. Participants who have households aged >60 years adhered about 7.9[AOR = 7.94, 95%CI (3.14–20.04)] times more than those with no households aged>60 years and those participants suspected to COVID-19 infection adhered to mitigation measures about 5.7 [AOR = 5.74, 95%CI (1.81–18.16)] times more than those who didn’t suspect (Table 3).

Table 3. Factors associated with adherence of COVID-19 mitigation measures among health care workers in referral hospitals of Amhara regional state of Ethiopia (N = 418).

Variables Category COR AOR P-value 95% CI
Monthly income ≤6990 1 1 1
6991–12800 0.21* 0.29 0.105 (0.06–1.29)
≥12801 0.18* 0.15 0.041 (0.02–0.92)
Hesitancy to COVID 19 vaccine No 1 1 1
Yes 0.09* 0.10 <0.001 (0.04–0.25)
Age <26 1 1 1
26–30 0.53* 0.09 0.001 (0.02–0.39)
≥31 0.97 0.25 0.065 (0.05–1.08)
Marital status single 1 1 1
Married 0.72* 1.33 0.422 (0.66–2.68)
Undergone COVID-19 19 test Yes 8.28* 6.64 <0.001 (3.10–14.22)
No 1 1 1
Information health by authorities clear 0.89 1.79 0.250 (0.66–4.88)
Inconsistent 0.37* 0.41 0.071 (0.15–1.07)
Unclear 1 1 1
Measures by Gov’t Not very adequate 1 1 1
Not adequate 0.29* 0.66 0.299 (0.29–1.45)
Adequate 1.28 4.60 0.003 (1.66–12.78)
Risk to get COVID-19 disease low 1 1 1
Moderate 0.89 2.40 0.136 (0.75–7.61)
High 3.09* 2.13 0.125 (0.81–5.60)
Fear to risk of sever COVID-19 disease No risk 0.13* 0.16 0.001 (0.06-.46)
Low risk 0.57* 0.45 10.07 (0.18–1.08)
Moderate/high risk 1 1 1
Household with age >60yrs Yes 1.8 0* 7.94 <0.001 (3.14–20.04)
No 1 1 1
Suspected to COVID-19 infection Yes 12.51* 5.74 0.003 (1.81–18.16)
No 1 1 1
Comorbidity No 1 1 1
Yes 0.14 0.35 0.347 (0.04–3.08)
Confident on COVID-19 vaccine Not confident 0.50 0.78 0.618 (0.29–2.07)
Confident 1 1 1

* = variables associated with the outcome variable at p-value<0.2, 1 = reference category of the respected variable.

Discussion

The current study aimed to determine adherence to COVID-19 mitigation measures and their associated factors. The adherence to COVID-19 mitigation measures among the participants was found to be 50.24%. The highest adherence (73.21%) was reported for handwashing whereas the lowest (56.94%) was reported for physical distancing.

The current finding of adherence was lower than the study conducted in Saudi Arabia (82%), the United Kingdom(80%), and the Kingdom of Saudi Arabia(80.9%) [1921]. The possible reasons for this difference might be the countries’ policy to prevent the pandemic, the monthly income difference of the study participants which might affect buying abilities of face masks, the data collection period differences in which all the studies conducted before the current study when vaccines were not found. But the current finding is more than the studies conducted in Western Ethiopia (22%) and southeast Ethiopia (21.6%) [15, 22]. The possible justification of the differences of the findings might be differences in COVID-19 prevention policies of the respected health institutions in the specified regions even though they are found in the same country.

Different independent variables in the current study affected the outcome variable. Monthly income, vaccine hesitancy, age, undergone COVID19 test, measurements taken by the national government, perception of the severity of the disease, presence of households with age>60 years and suspected to COVID-19 diagnosis significantly affected the adherence of COVID-19 measures in different directions.

Study participants in the current study with a monthly income of ≥12801birr adhered to COVID-19 measures less than those with a monthly income of ≤6990 birrs. This might be participants with low monthly income could use public transportation which might increase fear to acquire COVID-19 infection and cause them to adhere more [23, 24].

Participants who hesitate to take COVID -19 vaccines adhered lower than those who are volunteers to take the vaccine. The current study finding is supported by different studies conducted in Germany and China [25, 26]. The possible reason could be those who hesitate to take the vaccine might be individuals who believe COVID -19 is not a severe disease and even there is no such disease [2729].

Study participants with age groups of 26–30 years adhered to mitigation measures lower than those with age groups of <26 years. The current finding is in contradiction with the study conducted in South Ethiopia among the general community [30]. The discrepancy might be due to the current study conducted among health care workers but the previous study was conducted among the general community. The possible justification for the current study would be younger professionals might abide by mitigation measures more than elders due to negligence [31].

The experienced COVID-19 test increased the participants’ adherence in the current study. This might be as the participants who believe the existence of the pandemic is high and resulted to undergo COVID-19 test and consequently adhered to the mitigation measures than those who didn’t experience the COVID-19 test [1, 32]. Similarly, study participants who think that adequate measurements are taken by the national government adhered to mitigation measures more than those who think not taking adequate measurements. This could be those thinking the national government is taking adequate measurement trusted the national policies related to the pandemic and consequently adhered more [33, 34].

Study participants who perceived the severity of the disease as high adhered more than those who perceived no risk. Naturally, those who perceive the disease as severe are more committed to prevent it [35]. Participants who have households aged>60 years adhered more than those with no. The current finding is in line with the study conducted in Slovenia [36] This might be because individuals with age >60 years are at the risk of getting severe complications of the COVID -19 like death [37]. Therefore, those participants with households of age >60 years adhered more to prevent such complications of their households.

Another factor that increased the adherence to theCOVID-19 mitigation measures was suspected to COVID-19 infection. This finding is in agreement with the study finding conducted in Congo [38]. This might be as those suspected of the disease would not be allowed to enter the working area and consequently adhere to the preventive measures [39].

Conclusion

This study found lower adherence to COVID-19 mitigation measures among health care workers. Greater monthly income, hesitate to take the vaccine and older age decreased the adherence whereas undergone COVID-19 test, adequate measurement by the government, believing severity of the disease, households with age >60 years and suspected to COVID-19 diagnosis increased the adherence of mitigation measures. It is better to boost the practice of health care workers on the prevention methods of the COVID-19 pandemic in the current study setting since the adherence of the mitigation measures is lower than the recommended.

Limitations of the study

Since this study is cross-sectional, it shares the limitations of a cross-sectional study design. Social desirability bias could be introduced through study participants since the data collection technique was self-administered. To avoid the mentioned bias, the authors recommend doing further investigation using observational checklists.

Supporting information

S1 Dataset

(XLS)

S1 File

(DOCX)

Acknowledgments

The authors would like to acknowledge the healthcare workers for their collaboration during the data collection. Our gratitude also goes to data collectors in each hospital. Last but not least, we would like to pass our thanks to the University of Gondar for providing ethical clearance to conduct this study.

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Shewasinad Yehualashet S., et al., Predictors of adherence to COVID-19 prevention measure among communities in North Shoa Zone, Ethiopia based on health belief model: A cross-sectional study. PLoS One, 2021. 16(1): p. e0246006. doi: 10.1371/journal.pone.0246006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization, Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 2020.
  • 3.Wondimu W. and Girma B., Challenges and silver linings of COVID-19 in Ethiopia–short review. Journal of multidisciplinary healthcare, 2020. 13: p. 917. doi: 10.2147/JMDH.S269359 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tesfaye Z.T., et al., COVID-19-related knowledge, attitude and practice among hospital and community pharmacists in Addis Ababa, Ethiopia. Integrated Pharmacy Research & Practice, 2020. 9: p. 105. doi: 10.2147/IPRP.S261275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Azene Z.N., et al., Adherence towards COVID-19 mitigation measures and its associated factors among Gondar City residents: A community-based cross-sectional study in Northwest Ethiopia. PloS one, 2020. 15(12): p. e0244265. doi: 10.1371/journal.pone.0244265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Organization, W.H., Strengthening preparedness for COVID-19 in cities and urban settings. 2020.
  • 7.Amgain K., et al., Myths versus truths regarding the novel coronavirus disease (COVID-2019) outbreak. Journal of Karnali Academy of Health Sciences, 2020. 3(1). [Google Scholar]
  • 8.Abeya S.G., et al., Adherence to COVID-19 preventive measures and associated factors in Oromia regional state of Ethiopia. PloS one, 2021. 16(10): p. e0257373. doi: 10.1371/journal.pone.0257373 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Razu S.R., et al., Challenges faced by healthcare professionals during the COVID-19 pandemic: a qualitative inquiry from Bangladesh. Frontiers in public health, 2021: p. 1024. doi: 10.3389/fpubh.2021.647315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gholami M., et al., COVID-19 and healthcare workers: A systematic review and meta-analysis. International Journal of Infectious Diseases, 2021. 104: p. 335–346. doi: 10.1016/j.ijid.2021.01.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Xiong L.-J., et al., Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms. Translational Psychiatry, 2021. 11(1): p. 374. doi: 10.1038/s41398-021-01503-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Styra R., et al., Surviving SARS and living through COVID-19: Healthcare worker mental health outcomes and insights for coping. 2021. 16(11): p. e0258893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mekonen E.G., Gebrie M.H., and Jemberie S.M., Magnitude and associated factors of medication administration error among nurses working in Amhara Region Referral Hospitals, Northwest Ethiopia. Journal of Drug Assessment, 2020. 9(1): p. 151–158. doi: 10.1080/21556660.2020.1841495 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Getie, A., A. Wondmieneh, and T. Gebremeskel, Implementation of nursing process among nurses at Woldia Referral hospital, Northern Ethiopia: An institution-based cross-sectional study. 2021.
  • 15.Etafa W., et al., Healthcare workers’ compliance and its potential determinants to prevent COVID-19 in public hospitals in Western Ethiopia. BMC infectious diseases, 2021. 21(1): p. 1–8. doi: 10.1186/s12879-021-06149-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Walle Z., et al., COVID-19 Prevention Practices and Determinant Factors Among Healthcare Professionals Working in Hospitals of South Gondar Zone, Northwestern Ethiopia. Journal of Multidisciplinary Healthcare, 2021. 14: p. 2287–2298. doi: 10.2147/JMDH.S325127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.WHO. WHO’S top 10 threats to global health in 2019—ANMJ. 2021 [cited 2021 August 9]; https://anmj.org.au/whos-top-10-threats-to-global-health-in-2019/.
  • 18.Handebo S., et al., Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia. Plos one, 2021. 16(6): p. e0253499. doi: 10.1371/journal.pone.0253499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Albeladi F.I., et al., Level of Adherence to COVID-19 Preventive Measures Among Health Care Workers in Saudi Arabia. Cureus, 2021. 13(6). doi: 10.7759/cureus.15969 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Smith L.E., et al., Adherence to protective measures among health care workers in the UK; a cross-sectional study. medRxiv, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Al Khathlan N. and Padhi B.K., Adherence to COVID-19 Appropriate Behavior Among Respiratory Therapists: A Cross-Sectional Study in the Kingdom of Saudi Arabia. Frontiers in Public Health, 2021. 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zenbaba D., et al., Compliance towards infection prevention measures among health professionals in public hospitals, southeast Ethiopia: a cross-sectional study with implications of COVID-19 prevention. Tropical Medicine and Health, 2021. 49(1): p. 1–11. doi: 10.1186/s41182-021-00318-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Richert J., Martin I., and Schrader S., Beyond the immediate crisis: The SARS-CoV-2 pandemic and public transport strategy. 2020, Berlin: Mobility Institute Berlin. [Google Scholar]
  • 24.Gkiotsalitis K. and Cats O., Public transport planning adaption under the COVID-19 pandemic crisis: literature review of research needs and directions. Transport Reviews, 2021. 41(3): p. 374–392. [Google Scholar]
  • 25.Umakanthan, S. and S. Lawrence, Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study. 2022. [DOI] [PubMed]
  • 26.Zhang J., et al., Determinants of COVID-19 Vaccine Acceptance and Hesitancy: A Health Care Student-Based Online Survey in Northwest China. Front Public Health, 2021. 9: p. 777565. doi: 10.3389/fpubh.2021.777565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Alper S., Bayrak F., and Yilmaz O., Psychological correlates of COVID-19 conspiracy beliefs and preventive measures: Evidence from Turkey. Current psychology, 2020: p. 1–10. doi: 10.1007/s12144-020-00903-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Stoica C.A. and Umbreș R., Suspicious minds in times of crisis: determinants of Romanians’ beliefs in COVID-19 conspiracy theories. European Societies, 2021. 23(sup1): p. S246–S261. [Google Scholar]
  • 29.Pennycook G., et al., Fighting COVID-19 misinformation on social media: Experimental evidence for a scalable accuracy-nudge intervention. Psychological science, 2020. 31(7): p. 770–780. doi: 10.1177/0956797620939054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Tamirat T. and Abute L., Adherence towards COVID-19 prevention measures and associated factors in Hossana town, South Ethiopia, 2021. Int J Clin Pract, 2021. 75(12): p. e14530. doi: 10.1111/ijcp.14530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Health and C.P. Council, Professionalism in healthcare professionals. 2014, Health and Care Professions Council London. [Google Scholar]
  • 32.Asfaw L.S., Ayanto S.Y., and Aweke Y.H., Health-seeking behavior and associated factors among community in Southern Ethiopia: Community based cross-sectional study guided by Health belief model. BioRxiv, 2018: p. 388769. [Google Scholar]
  • 33.Ning Y., Ren R., and Nkengurutse G., China’s model to combat the COVID-19 epidemic: a public health emergency governance approach. Global health research and policy, 2020. 5(1): p. 1–4. doi: 10.1186/s41256-020-00161-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ha B.T.T., et al., Combating the COVID-19 epidemic: experiences from Vietnam. International journal of environmental research and public health, 2020. 17(9): p. 3125. doi: 10.3390/ijerph17093125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Aemro A., et al., Determinants of COVID-19 vaccine Hesitancy among Health Care Workers in Amhara region referral hospitals, Northwest Ethiopia: a cross-sectional study. Epidemiology & Infection, 2021: p. 1–23. doi: 10.1017/S0950268821002259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Turk E., et al., Adherence to COVID-19 mitigation measures: The role of sociodemographic and personality factors. Current Psychology, 2021. doi: 10.1007/s12144-021-02051-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Control, C.f.D. and Prevention, COVID-19 Risks and Vaccine Information for Older Adults. Druid Hills: CDC. 2021.
  • 38.Ditekemena J.D., et al., Factors associated with adherence to COVID-19 prevention measures in the Democratic Republic of the Congo (DRC): results of an online survey. 2021. 11(1): p. e043356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.van der Valk J., et al., Case-control study of patient characteristics, knowledge of the COVID-19 disease, risk behaviour and mental state in patients visiting an emergency room with COVID-19 symptoms in the Netherlands. PloS one, 2021. 16(4): p. e0249847. doi: 10.1371/journal.pone.0249847 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Paavani Atluri

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

21 Jan 2022

PONE-D-21-38230Adherence of Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional state of Ethiopia.PLOS ONE

Dear Dr. Beletech Fenti

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by March 7, 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Paavani Atluri

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following: 

● The name of the colleague or the details of the professional service that edited your manuscript

● A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

● A clean copy of the edited manuscript (uploaded as the new *manuscript* file).

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ.

6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 

7. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works, some of which you are an author.

- https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0257373

We would like to make you aware that copying extracts from previous publications, especially outside the methods section, word-for-word is unacceptable. In addition, the reproduction of text from published reports has implications for the copyright that may apply to the publications.

Please revise the manuscript to rephrase the duplicated text, cite your sources, and provide details as to how the current manuscript advances on previous work. Please note that further consideration is dependent on the submission of a manuscript that addresses these concerns about the overlap in text with published work.

We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough.

8.  Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Partly

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: N/A

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: No

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. since your study is a form of survey study, could you add study map?? to have more description for the reader?

2. correct place for ethics approval and consent to participate subtitle, and no need to write duplicate subtitle

3. No need to describe the study area / objective under discussion again!!

4. duplicate statements under abstract and conclusion

Reviewer #2: When you are writing the statement of the problem, it was nice if you put the paragraphs as follows;

• Concise description of the problem (severity, which group is affected, the distribution of the problem, what contribute to the problem, the consequences of the problem. what policies, and strategies are in palace to combat the problem , what is known, what is not known, why you are interested in the topic ( what gaps exist)

• You can use few studies to describe the problem but it’s recommended to summaries studies with similar findings in one statement

Better to put in such way Binary logistic regression was be employed to identify factors associated with adherence of COVID-19 mitigation measures. Initially bivariate analysis was done and variables with p-value of below 0.2 was identified as candidate for multi-variable analysis. Then multi-variable analysis was done and adjusted odd ration was computed and interpreted. A p-value less than 0.05 is cut-off point for determining the significance of association. Result of the study was presented in text, table and graphs.

Reviewer #3: None

Reviewer #4: I appreciate the authors for doing a research on the current pandemic disease. But I have some concerns.

1. Abstract is OK.

2. Methods: Please provide further detail how Random selection was carried out to select study participants.

3. Please try to provide the detail of the specific questions used to assess adherence level for all the three components.

4. Discussion: The justification provided by the authors on the discrepancy between the studies conducted in other part of the same country may be due to the difference in tool used to assess adherence. Please provide a clear justification why you preferred using a tool with only three components to assess adherence level when others used different tool( discussion part second paragraph line 13-14)

5. In discussion, the author only compared their finding with other studies on the adherence level and no comparisons were made with other studies for factors affecting adherence level.

6. Discussion part should cover the interpretation of the finding, comparison with other studies, explanation for discrepancies if it exists, and the limitation of the study. The discussion part could be more than what the authors provided.

Reviewer #5: dear authors thank you for your effort, i have some comments and questions in your work

Abstract

1) the conclusion part of the abstract is not based on your finding, its a general kind of conclusion

Introduction

2)your in introduction is not well conceptualized, you did not show the gap for doing this research

you said "there is no paper locally" but there are number of papers on covid mitigation measures of health workers even in Ethiopia

methods

3) you have defined perceived susceptibility and risk of getting disease as the same variables when they actually are very different variable

4)you measured perceived severity and risk of getting severe disease as the same variable when they actually are different variable

5)you measured perceptions categorically which has a lot of limitation, what's your base to categorize perception?

i recommend you to treat perception items as continuous variable

6)how do you measured vaccine hesitancy, covid mitigation measures, perceived susceptibility and perceived severity please attach the questionnaire i want to see the questionnaire

RESULT PART

7)you have wrongly interpreted the odds ratios that are less than one

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Abass Abdul-Karim

Reviewer #4: No

Reviewer #5: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-21-38230 commented.pdf

PLoS One. 2022 Aug 5;17(8):e0272570. doi: 10.1371/journal.pone.0272570.r002

Author response to Decision Letter 0


26 Feb 2022

26/02/2022

Paavani Atluri,

PLOS ONE

Dear Paavani Atluri,

Subject: Submission of revised manuscript entitled as “Adherence of Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional state of Ethiopia” (PONE-D-21-38230).

Thank you for email dated on January 21/2022 enclosing the Editorial member’s and the reviewer’s comments. We have carefully revised the manuscript and incorporated their comments accordingly. Our responses are given in point-by-point response below.

We hope the revised version is suitable for publication and look forward to hearing from you in due courses.

Sincerely

Beletech Fentie

University of Gondar, College of Medicine and health Sciences, School of Nursing, Department of pediatrics and child health nursing.

Point by point responses to Editorial Board Member’s and Reviewers’ comments.

Title of paper: Adherence of Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional state of Ethiopia

Editorial comments:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming

Authors Response: Thank you very much for your constructive comments and suggestions. We tried to incorporate your comments accordingly and we hope the manuscript meets PLOS ONE’s style requirements.

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Authors’ Response: Thank you very much for your constructive comments. Written informed consent was obtained from each participant using communication channels (telegram and email) and those who agreed to participate were included in the study and this information is provided in the Ethics approval and consent to participate section of the manuscript. This study did not include the minors.

3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

Authors’ Response: Thank you very much for your constructive comments. We tried to address the comments in the manuscript. Since the authors are in low income country to cover the cost, online grammar checker was used to correct the spelling and grammar errors (Grammarly.com)

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly.

Authors’ Response: Thank you very much for your comments. We have uploaded the minimal anonymized data set necessary to replicate our study findings as Supporting Information file.

5. PLOS requires an ORCID ID for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016.

Authors’ Response: Thank you very much for your comment. The corresponding author has validated her ORCID ID in Editorial Manager.

6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

Authors’ Response: Thank you very much for your comment. We deleted the ethics statement that was included other than the methods section in the manuscript.

7. Thank you for submitting the above manuscript to PLOS ONE. During our internal evaluation of the manuscript, we found significant text overlap between your submission and the following previously published works, some of which you are an author.

- https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0257373

Authors’ Response: Thank you very much for your comments. We tried to revise the manuscript and rephrase the duplicated text and cite the sources. The published article you mentioned (https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0257373) is conducted in the general community but the current study is conducted in health care providers which is different population in the general community(i.e The study populations of the already published article and the current manuscript is totally different). Therefore, we think there is no duplication.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice

Authors’ Response: Thank you very much for your comments. We have assessed the references as much we can and the references are correct and there is no retracted article cited.

Reviewer #1:

1. Since your study is a form of survey study, could you add study map?? to have more description for the reader?

Author’s response:

• Based on the comment, the authors incorporated a study map in the revised manuscript.

2. Correct place for ethics approval and consent to participate subtitle, and no need to write duplicate subtitle.

Author’s response:

• Thank you for the comments.

• Based on the comment, the authors removed the ethics section from the declaration part and only incorporated it in the method section.

3. No need to describe the study area / objective under discussion again!!

Author’s response:

• Thank you. The authors removed it in the revised manuscript.

4. Duplicate statements under abstract and conclusion.

Author’s response:

• Thank you for your concern. In the revised manuscript, the authors rephrase the idea in the abstract section.

Reviewer #2:

1. When you are writing the statement of the problem, it was nice if you put the paragraphs as follows; • Concise description of the problem (severity, which group is affected, the distribution of the problem, what contribute to the problem, the consequences of the problem. what policies, and strategies are in palace to combat the problem , what is known, what is not known, why you are interested in the topic ( what gaps exist).

Authors Response: Thank you very much for your constructive comments and suggestions. We tried to address your comments and suggestions accordingly in the manuscript.

2. Better to put in such way Binary logistic regression was be employed to identify factors associated with adherence of COVID-19 mitigation measures. Initially bivariate analysis was done and variables with p-value of below 0.2 were identified as candidate for multi-variable analysis. Then multi-variable analysis was done and adjusted odd ration was computed and interpreted. A p-value less than 0.05 is cut-off point for determining the significance of association. Result of the study was presented in text, table and graphs.

Author’s response: Based on the comments, the authors revised this paragraph under the subheading of the “Data processing and analysis” section of the manuscript.

Reviewer #3:

None

Author’s response: Reviewer 3 didn't have any comments to the authors regarding the manuscript.

Reviewer #4:

I appreciate the authors for doing a research on the current pandemic disease. But I have some concerns.

Author’s response:

•Thank you for your appreciation and positive feedback.

1. Abstract is OK.

Author’s response: Thank you.

2. Methods: Please provide further detail how Random selection was carried out to select study participants.

Author’s response: Thank you for your concern. Based on the comments, the authors incorporated the details of randomization in the revised manuscript.

3. Please try to provide the detail of the specific questions used to assess adherence level for all the three components.

Authors Response: Thank you very much for your constructive comments and suggestions.

We tried to address all the issues raised in operational definition part of the revised manuscript.

4. Discussion: The justification provided by the authors on the discrepancy between the studies conducted in other part of the same country may be due to the difference in tool used to assess adherence. Please provide a clear justification why you preferred using a tool with only three components to assess adherence level when others used different tool (discussion part second paragraph line 13-14)

Authors Response: Thank you very much for your constructive comments.

The previous studies used more adherence components since they were conducted in the initial phase of the pandemic (like there were lockdown, no public transportation, satay at home rules, mass gathering and etc. in the world). Since stay at home, restriction of public transportation, mass gathering and any lockdown are removed; we used the three major components used to prevent the COVID- 19 pandemic. The three components are also highly recommended by world health organization and many other health authorities and organization including Ethiopian ministry of health.

5. In discussion, the author only compared their finding with other studies on the adherence level and no comparisons were made with other studies for factors affecting adherence level.

Authors’ Response: Thank you very much for your constructive comments. In some extent, we tried to address the comment in the manuscript, but as our search we didn’t get any similar factors associated to adherence in other articles conducted in health care providers. That is why we left not discussed the factors variables. Instead, we tried to show scientific facts why these factors influence the adherence.

6. Discussion part should cover the interpretation of the finding, comparison with other studies, explanation for discrepancies if it exists, and the limitation of the study. The discussion part could be more than what the authors provided.

Authors Response: Thank you very much for your constructive comments. We tried to elaborate the discussion part as per your comment and suggestion

Reviewer#5

Dear authors, thank you for your effort, I have some comments and questions in your work

Author’s response: Thank you for your feedback.

Abstract:

1) The conclusion part of the abstract is not based on your finding, it’s a general kind of conclusion

Author’s response: Thank you. We revised and retyped it based on the findings of this study.

Introduction:

2) Your introduction is not well conceptualized, you did not show the gap for doing this research, you said "there is no paper locally" but there are number of papers on covid mitigation measures of health workers even in Ethiopia

Authors Response: Thank you very much for your constructive comment. We tried to address the comments in the manuscript. But still we couldn’t get any article published in the study setting among health care providers even in Ethiopia.

Methods:

3) You have defined perceived susceptibility and risk of getting disease as the same variables when they actually are very different variable

Author’s response:

According to the health belief model (HBM),

• Perceived susceptibility is defined as a person’s subjective perception about their chance or risk of getting a certain condition, in this case, COVID-19.

• This means the literal definition of “Perceived susceptibility” is “perceived risk of getting a disease”.

• That was why the authors used the phrase “Perceived susceptibility/risk of getting COVID-infection”, which is to mean “perceived susceptibility of getting COVID-infection” or “perceived risk of getting COVID-infection”.

• In short, based on the definition of HBM, the authors used these two terms interchangeably.

• But, to avoid ambiguity, the authors used only “perceived susceptibility” in the revised manuscript.

4) You measured perceived severity and risk of getting severe disease as the same variable when they actually are different variable

Author’s response:

• According to HBM, “perceived severity” refers to a person’s belief about the seriousness or severity of a disease.

• i.e. Perceived severity of COVID-19 infection = Perceived risk of developing sever COVID-19 infection.

• That was why the authors used the term “perceived severity/risk of developing the severe disease”.

• But, to avoid ambiguity, the authors used only “perceived severity” in the revised manuscript.

5) You measured perceptions categorically which has a lot of limitation, what's your base to categorize perception? I recommend you to treat perception items as continuous variable

Author’s response:

• Thank you for your recommendation. But, we assessed it by using the Likert scale, as other literature has used before. After that, re-categorization was considered in a few variables if the chi-square assumption was not fulfilled.

6) How do you measured vaccine hesitancy, COVID-19 mitigation measures, perceived susceptibility and perceived severity please attach the questionnaire I want to see the questionnaire

Author’s response:

• The way of measuring these variables was stated under the subheading “Operational Definition” of the method section.

• Based on your request, we attached the questionnaire during the re-submission of the revised manuscript as a “supplementary file” .

Result:

7) You have wrongly interpreted the odds ratios that are less than one

Author’s response:

We think the interpretations of the Odds rations are correct. For example:- AOR=0.15 means study participants adhered 15% to mitigation measures. In another way, it can be interpreted as study participants were 85% less likely adhere to mitigation measures of COVID-19. That is why we used one of the two ways of interpretations. If authors are mistaken, they can correct with reasonable justifications you will give us.

Attachment

Submitted filename: PLOS point by point response .docx

Decision Letter 1

Paavani Atluri

22 Jul 2022

Adherence to Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional State of Ethiopia

PONE-D-21-38230R1

Dear Dr. Fentie,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Paavani Atluri

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #4: No

**********

Acceptance letter

Paavani Atluri

28 Jul 2022

PONE-D-21-38230R1

Adherence to Covid-19 mitigation measures and its associated factors among health care workers at Referral Hospitals in Amhara Regional State of Ethiopia

Dear Dr. Fentie:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Paavani Atluri

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Dataset

    (XLS)

    S1 File

    (DOCX)

    Attachment

    Submitted filename: PONE-D-21-38230 commented.pdf

    Attachment

    Submitted filename: PLOS point by point response .docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES